A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2.
Year: 1996
Type: article
Source: PubMed
Authors: W W Cao, P N Kao, Y Aoki, J C Xu, R A Shorthouse, R E Morris
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2420851574